Cadent Therapeutics
Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.
2
Funding Rounds
$80.0m
Money raised
Overview
Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.
- Business model: B2B
Funding series
Funding Series Analysis
The company Cadent Therapeutics has raised a total of $40m in funding over 2 rounds.
Key Insights:
- Cadent Therapeutics Series B round, November 2018: $40m
- Cadent Therapeutics funding round, November 2018: $40m
Cadent Therapeutics Series B round, November 2018
$40m
Cadent Therapeutics funding round, November 2018
$40m
Industries
Cadent Therapeutics is active in the following industries:
- Healthcare
- Medicine
- Neurobiology
- Neuroscience